We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Annual Mammogram Proves Most Effective to Prevent Cancer

By HospiMedica International staff writers
Posted on 29 Aug 2017
Researchers comparing breast cancer screening recommendations have found that annual screening starting from age 40 would reduce breast cancer-specific deaths by the highest percentage.

The researchers used computer models to investigate the effectiveness of three annual screening strategies that were also programmed to look for risks related to screening such as callbacks for more imaging scans, or a needle biopsy to find false positive results.

The study was led by researchers from Weill Cornell Medicine (New York, NY, USA), New York-Presbyterian (New York, NY, USA), and the University of Colorado School of Medicine (Aurora, CO, USA), and was published in the August 21, 2017, issue of the journal Cancer. More...
The goal of the study was intended to uncover insights to help women make the best choices for mammography screening.

The first screening strategy consisted of screening from age 40 years; the second consisted of annual screening beginning at ages of 45 to 54 years, with additional biennial screening for 55 to 79 year olds. The third strategy consisted only of biennial screening for 50 to 74 year olds. The results showed that screening beginning at age 40 reduced breast cancer-specific deaths by nearly 40%, while the other recommendations reduced deaths from the disease by between 23% and 31%.

Elizabeth Kagan Arleo, MD, Weill Cornell Medicine, and New York-Presbyterian, said, "Our findings are important and novel because this is the first time the three most widely discussed recommendations for screening mammography have been compared head to head. Our research would be put to good use if, because of our findings, women chose to start annual screening mammography starting at age 40. Over the long term, this would be significant because fewer women would die from breast cancer."

Related Links:
Weill Cornell Medicine
New York-Presbyterian
University of Colorado School of Medicine

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Immobilization System
Cranial 4Pi Immobilization
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.